XML 51 R38.htm IDEA: XBRL DOCUMENT
v3.25.3

Segments of Business (Tables) | 9 Months Ended
--- | ---
Sep. 28, 2025
Segment Reporting [Abstract] |
Schedule of Reportable Business Segments | The Company operates the business through the following three reportable business segments based on product categories:
Reportable Segments | Product Categories
Self Care | Cough, Cold, and Allergy
| Pain Care
| Other Self Care (Digestive Health, Smoking Cessation, Eye Care, and Other)
Skin Health and Beauty | Face and Body Care
| Hair, Sun, and Other
Essential Health | Oral Care
| Baby Care
| Other Essential Health (Women’s Health, Wound Care, and Other)
Schedule of Product Categories as a Percent of Net Sales | The Company’s product categories as a percentage of Net sales for the fiscal three and nine months ended September 28, 2025 and September 29, 2024 were as follows:
|  | Fiscal Three Months Ended |  | Fiscal Nine Months Ended
Product Categories |  | September 28, 2025 |  | September 29, 2024 |  | September 28, 2025 |  | September 29, 2024 |  |
Cough, Cold, and Allergy |  | 13 | % |  | 13 | % |  | 14 | % |  | 14 | % |  |
Pain Care |  | 13 |  |  | 14 |  |  | 13 |  |  | 13 |  |  |
Other Self Care |  | 16 |  |  | 15 |  |  | 15 |  |  | 15 |  |  |
Face and Body Care |  | 20 |  |  | 20 |  |  | 19 |  |  | 19 |  |  |
Hair, Sun, and Other |  | 8 |  |  | 7 |  |  | 8 |  |  | 9 |  |  |
Oral Care |  | 10 |  |  | 11 |  |  | 11 |  |  | 10 |  |  |
Baby Care |  | 9 |  |  | 9 |  |  | 9 |  |  | 9 |  |  |
Other Essential Health |  | 11 |  |  | 11 |  |  | 11 |  |  | 11 |  |  |
Total |  | 100 | % |  | 100 | % |  | 100 | % |  | 100 | % |  |
Schedule of Segment Net Sales and Adjusted Operating Income | Segment net sales and Segment adjusted operating income for the fiscal three and nine months ended September 28, 2025 and September 29, 2024 were as follows:
|  | Fiscal Three Months Ended |  |
|  | September 28, 2025 |  | September 29, 2024 |  |
(Dollars in Millions) |  | Self Care |  | Skin Health and Beauty |  | Essential Health |  | Total |  | Self Care |  | Skin Health and Beauty |  | Essential Health |  | Total |  |  |  |
Net sales |  | $ | 1,564 |  |  | $ | 1,038 |  |  | $ | 1,162 |  |  | $ | 3,764 |  |  | $ | 1,625 |  |  | $ | 1,072 |  |  | $ | 1,202 |  |  | $ | 3,899 |  |  |  |  |
Segment adjusted Cost of sales(1) |  | 546 |  |  | 401 |  |  | 512 |  |  | 1,459 |  |  | 569 |  |  | 421 |  |  | 539 |  |  | 1,529 |  |  |  |  |
Other segment expense items(2) |  | 498 |  |  | 500 |  |  | 343 |  |  | 1,341 |  |  | 499 |  |  | 460 |  |  | 372 |  |  | 1,331 |  |  |  |  |
Segment adjusted operating income |  | $ | 520 |  |  | $ | 137 |  |  | $ | 307 |  |  | $ | 964 |  |  | $ | 557 |  |  | $ | 191 |  |  | $ | 291 |  |  | $ | 1,039 |  |  |  |  |
Reconciliation to Income before taxes |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Less: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Depreciation(3) |  |  |  |  |  |  |  | 75 |  |  |  |  |  |  |  |  | 94 |  |  |  |  |
Amortization of intangible assets(4) |  |  |  |  |  |  |  | 66 |  |  |  |  |  |  |  |  | 66 |  |  |  |  |
Separation-related costs(5) |  |  |  |  |  |  |  | 17 |  |  |  |  |  |  |  |  | 85 |  |  |  |  |
Restructuring expenses and operating model optimization initiatives(6) |  |  |  |  |  |  |  | 97 |  |  |  |  |  |  |  |  | 38 |  |  |  |  |
Conversion of stock-based awards(8) |  |  |  |  |  |  |  | 1 |  |  |  |  |  |  |  |  | 6 |  |  |  |  |
Founder Shares(9) |  |  |  |  |  |  |  | (4) |  |  |  |  |  |  |  |  | 7 |  |  |  |  |
Other operating expense, net |  |  |  |  |  |  |  | 1 |  |  |  |  |  |  |  |  | 7 |  |  |  |  |
General corporate/unallocated expenses |  |  |  |  |  |  |  | 82 |  |  |  |  |  |  |  |  | 82 |  |  |  |  |
Operating income |  |  |  |  |  |  |  | $ | 629 |  |  |  |  |  |  |  |  | $ | 654 |  |  |  |  |
Other expense (income), net |  |  |  |  |  |  |  | 10 |  |  |  |  |  |  |  |  | (19) |  |  |  |  |
Interest expense, net |  |  |  |  |  |  |  | 93 |  |  |  |  |  |  |  |  | 96 |  |  |  |  |
Income before taxes |  |  |  |  |  |  |  | $ | 526 |  |  |  |  |  |  |  |  | $ | 577 |  |  |  |  |
|  | Fiscal Nine Months Ended |  |  |  |
|  | September 28, 2025 |  | September 29, 2024 |  |  |  |
(Dollars in Millions) |  | Self Care |  | Skin Health and Beauty |  | Essential Health |  | Total |  | Self Care |  | Skin Health and Beauty |  | Essential Health |  | Total |  |  |  |  |  |  |  |  |  |  |  |
Net sales |  | $ | 4,786 |  |  | $ | 3,074 |  |  | $ | 3,484 |  |  | $ | 11,344 |  |  | $ | 4,958 |  |  | $ | 3,229 |  |  | $ | 3,606 |  |  | $ | 11,793 |  |  |  |  |  |  |  |  |  |  |  |  |
Segment adjusted Cost of sales(1) |  | 1,681 |  |  | 1,236 |  |  | 1,539 |  |  | 4,456 |  |  | 1,693 |  |  | 1,324 |  |  | 1,597 |  |  | 4,614 |  |  |  |  |  |  |  |  |  |  |  |  |
Other segment expense items(2) |  | 1,492 |  |  | 1,460 |  |  | 1,048 |  |  | 4,000 |  |  | 1,573 |  |  | 1,403 |  |  | 1,095 |  |  | 4,071 |  |  |  |  |  |  |  |  |  |  |  |  |
Segment adjusted operating income |  | $ | 1,613 |  |  | $ | 378 |  |  | $ | 897 |  |  | $ | 2,888 |  |  | $ | 1,692 |  |  | $ | 502 |  |  | $ | 914 |  |  | $ | 3,108 |  |  |  |  |  |  |  |  |  |  |  |  |
Reconciliation to Income before taxes |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Less: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Depreciation(3) |  |  |  |  |  |  |  | 226 |  |  |  |  |  |  |  |  | 238 |  |  |  |  |  |  |  |  |  |  |  |  |
Amortization of intangible assets(4) |  |  |  |  |  |  |  | 193 |  |  |  |  |  |  |  |  | 212 |  |  |  |  |  |  |  |  |  |  |  |  |
Separation-related costs(5) |  |  |  |  |  |  |  | 79 |  |  |  |  |  |  |  |  | 231 |  |  |  |  |  |  |  |  |  |  |  |  |
Restructuring expenses and operating model optimization initiatives(6) |  |  |  |  |  |  |  | 232 |  |  |  |  |  |  |  |  | 146 |  |  |  |  |  |  |  |  |  |  |  |  |
Impairment charges(7) |  |  |  |  |  |  |  | — |  |  |  |  |  |  |  |  | 578 |  |  |  |  |  |  |  |  |  |  |  |  |
Conversion of stock-based awards(8) |  |  |  |  |  |  |  | 5 |  |  |  |  |  |  |  |  | 34 |  |  |  |  |  |  |  |  |  |  |  |  |
Founder Shares(9) |  |  |  |  |  |  |  | 4 |  |  |  |  |  |  |  |  | 24 |  |  |  |  |  |  |  |  |  |  |  |  |
Other operating expense, net |  |  |  |  |  |  |  | 19 |  |  |  |  |  |  |  |  | 29 |  |  |  |  |  |  |  |  |  |  |  |  |
General corporate/unallocated expenses |  |  |  |  |  |  |  | 251 |  |  |  |  |  |  |  |  | 258 |  |  |  |  |  |  |  |  |  |  |  |  |
Operating income |  |  |  |  |  |  |  | $ | 1,879 |  |  |  |  |  |  |  |  | $ | 1,358 |  |  |  |  |  |  |  |  |  |  |  |  |
Other expense, net |  |  |  |  |  |  |  | 26 |  |  |  |  |  |  |  |  | 6 |  |  |  |  |  |  |  |  |  |  |  |  |
Interest expense, net |  |  |  |  |  |  |  | 281 |  |  |  |  |  |  |  |  | 283 |  |  |  |  |  |  |  |  |  |  |  |  |
Income before taxes |  |  |  |  |  |  |  | $ | 1,572 |  |  |  |  |  |  |  |  | $ | 1,069 |  |  |  |  |  |  |  |  |  |  |  |  |
(1) The Company defines Segment adjusted cost of sales as Cost of sales adjusted for amortization of intangible assets, Separation-related costs, conversion of stock-based awards, Founder Shares (as defined below), operating model optimization initiatives, and general corporate/unallocated expenses. (2) Other segment expense items for each reportable segment include brand support, employee-related costs, shipping and handling costs, research and development costs, and certain other operating expenses (income). (3) Depreciation consists of depreciation of property, plant, and equipment and amortization of integration and development costs capitalized in connection with cloud computing arrangements. (4) Relates to the amortization of definite-lived intangible assets (primarily trademarks, trade names, and customer lists) over their estimated useful lives. (5) Separation-related costs includes depreciation expense on Separation-related assets for the fiscal three and nine months ended September 29, 2024. See Note 1, “Description of the Company and Summary of Significant Accounting Policies—Separation-Related Costs,” for additional information regarding Separation-related costs. (6) Restructuring expenses and operating model optimization initiatives relate to the 2024 Multi-Year Restructuring Initiative (as defined in Note 15, “Restructuring Expenses and Operating Model Optimization Initiatives”). See Note 15, “Restructuring Expenses and Operating Model Optimization Initiatives,” for additional information. (7) Impairment charges includes $488 million recognized in the fiscal three months ended June 30, 2024 in relation to Dr.Ci:Labo® long-lived assets, $68 million recognized in the fiscal three months ended March 31, 2024 on the held for sale asset associated with the Company’s former corporate headquarters in Skillman, New Jersey, and $22 million recognized in the fiscal three months ended June 30, 2024 on certain software development assets. See Note 1, “Description of the Company and Summary of Significant Accounting Policies—Impairment Charges,” for additional information. (8) Segment adjusted operating income excludes the impact of the conversion of stock-based awards that occurred on August 23, 2023. The adjustment represents the net impact of the gain on reversal of previously recognized stock-based compensation expense, offset by stock- based compensation expense recognized in the fiscal three and nine months ended September 28, 2025 and September 29, 2024 relating to employee services provided prior to the Separation. (9) On August 25, 2023, the Company’s Compensation & Human Capital Committee approved equity grants to individuals employed by Kenvue as of October 2, 2023 (the “Founder Shares”). On October 2, 2023, the Founder Shares were granted to all Kenvue employees in the form of stock options and PSUs to executive officers and either stock options and PSUs or RSUs to non-executive individuals. Depreciation and amortization by reportable segment for the fiscal three and nine months ended September 28, 2025 and September 29, 2024 were as follows:
|  | Fiscal Three Months Ended |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | Fiscal Nine Months Ended
(Dollars in Millions) |  | September 28, 2025 |  | September 29, 2024 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | September 28, 2025 |  | September 29, 2024 |  |
Self Care |  | $ | 52 |  |  | $ | 70 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ | 154 |  |  | $ | 155 |  |  |
Skin Health and Beauty |  | 32 |  |  | 46 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 94 |  |  | 143 |  |  |
Essential Health |  | 57 |  |  | 66 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 171 |  |  | 174 |  |  |
Total depreciation and amortization(1) |  | $ | 141 |  |  | $ | 182 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ | 419 |  |  | $ | 472 |  |  |
(1) Depreciation consists of depreciation of property, plant, and equipment and amortization of integration and development costs capitalized in connection with cloud computing arrangements. Amortization relates to the amortization of intangible assets.

X
- Definition Schedule Of Reportable Segments + References No definition available. + Details
Name: | kvue_ScheduleOfReportableSegmentsTableTextBlock
Namespace Prefix: | kvue_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of entity-wide revenues from external customers for each product or service or each group of similar products or services if the information is not provided as part of the reportable operating segment information. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 40 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40 + Details
Name: | us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 25 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-25 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30 + Details
Name: | us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration